Nuclear Antigen Antikörper
-
- Target Alle Nuclear Antigen (IPO-38) Antikörper anzeigen
- Nuclear Antigen (IPO-38)
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Nuclear Antigen Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Verwendungszweck
- Mouse anti-Human/Mouse/Rat IPO-38 Antibody (Proliferation Marker) [IHC only]
- Spezifität
- Nuclear
- Aufreinigung
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
- Immunogen
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
- Top Product
- Discover our top product IPO-38 Primärantikörper
-
-
- Applikationshinweise
- Prediluted format : incubate for 30 min at RT (2)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Prediluted in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide, For IHC use only
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
- Target
- Nuclear Antigen (IPO-38)
- Andere Bezeichnung
- IPO38 (IPO-38 Produkte)
- Hintergrund
-
Target Description: Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO38 may be a useful marker of cell proliferation during monitoring of tumor progression.
-